tangeretin has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, XX; Feng, SL; He, F; Leung, EL; Xie, Y; Yan, PY; Yao, XJ; Zhou, H | 1 |
| Cao, Y; Charoensinphon, N; Dong, P; Ho, CT; Li, S; Ngauv, P; Qiu, P; Xiao, H; Zheng, J | 1 |
| Chang, YH; Chen, YK; Chung, TW; Ho, CT; Li, S; Li, YR; Lin, CC; Tan, KT; Wang, BY | 1 |
3 other study(ies) available for tangeretin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mutation; NF-E2-Related Factor 2; Paclitaxel; Protein Kinase Inhibitors; Quinazolines; Reactive Oxygen Species | 2022 |
5-demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Flavones; Humans; Lung Neoplasms | 2013 |
Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo.
Topics: Animals; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavones; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Membrane Potential, Mitochondrial; Mice; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays | 2016 |